Clinically actionable pharmacogenomic landscape of antidepressants and antipsychotics in Qatar: A population-based cohort study
Dinesh Velayutham, Kholoud Bastaki, Areeba Irfan, Mohammed Abuhaliqa, Aisha AlMulla, Suhaila Ghuloum, Muhammad Waqar Azeem, Munir Pirmohamed, Puthen Veettil Jithesh
This study identifies actionable genetic variants in Qatar's population for antidepressants and antipsychotics, revealing high prevalence of metabolizer phenotypes impacting drug response.
Cambridge Prisms Precision Medicine · Jan 1, 2025Peer-reviewedGenetic & Genomic Medicine